Select Medical Sale Faces Investigation Over $16.50 Executive-Led Consortium Deal
Halper Sadeh LLC is investigating Select Medical Holdings’ proposed sale to an executive-led consortium for $16.50 per share, alleging insiders may gain preferential financial benefits and that transaction terms could limit competing offers. Shareholders can pursue legal rights on a contingent fee basis to seek increased consideration or other relief.
1. Investigation Initiated
Halper Sadeh LLC initiated an investigation into Select Medical’s $16.50 per share agreement with an executive-led consortium, citing potential breaches of fiduciary duty and preferential insider benefits. The firm highlights provisions that may restrict superior competing bids and reduce shareholder value.
2. Shareholder Rights and Remedies
Shareholders can engage counsel on a contingent fee arrangement without upfront costs to pursue increased deal consideration, additional disclosures or other relief. The investigation could extend deal timelines and pressure the consortium to revise terms or face litigation.